Publication: Disease activity assessment by ASDAS in AS: active disease requiring TNF-antagonist therapy can be well discriminated with different ASDAS sets
| dc.contributor.authors | Aydin, Sibel Zehra; Can, Meryem; Atagunduz, Pamir; Direskcneli, Haner | |
| dc.date.accessioned | 2022-03-10T17:49:50Z | |
| dc.date.accessioned | 2026-01-11T11:17:59Z | |
| dc.date.available | 2022-03-10T17:49:50Z | |
| dc.date.issued | 2009 | |
| dc.identifier.doi | doiWOS:000272278400056 | |
| dc.identifier.issn | 0392-856X | |
| dc.identifier.uri | https://hdl.handle.net/11424/221227 | |
| dc.identifier.wos | WOS:000272278400056 | |
| dc.language.iso | eng | |
| dc.publisher | CLINICAL & EXPER RHEUMATOLOGY | |
| dc.relation.ispartof | CLINICAL AND EXPERIMENTAL RHEUMATOLOGY | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.title | Disease activity assessment by ASDAS in AS: active disease requiring TNF-antagonist therapy can be well discriminated with different ASDAS sets | |
| dc.type | conferenceObject | |
| dc.type.sub | meetingabstract | |
| dspace.entity.type | Publication | |
| oaire.citation.endPage | 720 | |
| oaire.citation.issue | 5 | |
| oaire.citation.startPage | 720 | |
| oaire.citation.title | CLINICAL AND EXPERIMENTAL RHEUMATOLOGY | |
| oaire.citation.volume | 27 |
